Related Experiment Videos
Gamma heavy chain disease. Ultrastructural and immunohistochemical study
Acta Pathologica Japonica
|July 1, 1983
Summary
Gamma heavy chain disease (gamma-HCD) involves the proliferation of B-cells producing abnormal gamma heavy chain proteins. Studies show these cells mature into proplasmacytes and plasma cells, indicating a single clone origin.
Area of Science:
- Immunology
- Hematology
- Cell Biology
Background:
- Gamma heavy chain disease (gamma-HCD) is a rare lymphoproliferative disorder.
- Understanding the cellular origins and maturation pathways in gamma-HCD is crucial for diagnosis and treatment.
Observation:
- Electron microscopy revealed proliferating cells in gamma-HCD patients exhibit stages of maturation from immunoblasts to plasma cells.
- Immunohistochemical studies using immunoperoxidase and enzyme-labeled antibody techniques identified these proliferating cells as immunoblasts, plasmablasts, proplasmacytes, and plasma cells.
Findings:
- Proliferating cells consistently reacted positively for anti-gamma-heavy chain and anti-Fc fragment (IgG) serum.
- In one case with Bence Jones protein, cells also showed positivity for anti-kappa light chain serum.
- These findings suggest a single clone proliferation of B-cells synthesizing the specific gamma-HCD protein.
Implications:
- The predominant proliferation of proplasmacytes and plasma cells points to a specific B-cell lineage involvement in gamma-HCD.
- This detailed cellular characterization aids in understanding the pathogenesis of gamma-HCD.
- Further research into B-cell maturation in this disease could reveal novel therapeutic targets.